FMR LLC 13D/13G Filings for Seres Therapeutics, Inc. (MCRB)

FMR LLC 13D and 13G filings for Seres Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-12
09:22 am
Purchase		 2024-12-31 13G Seres Therapeutics, Inc.
MCRB		 FMR LLC 1,090,585
12.800%		 121,156increase
(+12.50%)		 Filing
2024-02-09
09:49 am
Purchase		 2024-02-08 13G Seres Therapeutics, Inc.
MCRB		 FMR LLC 969,429
14.999%		 34,991increase
(+3.74%)		 Filing
2023-02-09
12:31 pm
Purchase		 2023-02-09 13G Seres Therapeutics, Inc.
MCRB		 FMR LLC 934,438
14.999%		 245,585increase
(+35.65%)		 Filing
2022-02-09
10:24 am
Purchase		 2022-02-08 13G Seres Therapeutics, Inc.
MCRB		 FMR LLC 688,854
14.999%		 122,025increase
(+21.53%)		 Filing
2021-02-08
10:33 am
Purchase		 2021-02-05 13G Seres Therapeutics, Inc.
MCRB		 FMR LLC 566,829
12.423%		 26,804increase
(+4.96%)		 Filing
2020-09-10
10:03 am
Purchase		 2020-09-09 13G Seres Therapeutics, Inc.
MCRB		 FMR LLC 540,025
12.095%		 215,069increase
(+66.18%)		 Filing